| Literature DB >> 23490339 |
Yuri V Bobryshev1, Tatyana A Shchelkunova, Ivan A Morozov, Petr M Rubtsov, Igor A Sobenin, Alexander N Orekhov, Alexander N Smirnov.
Abstract
One of hypotheses of atherosclerosis is based on a presumption that the zones prone to the development of atherosclerosis contain lysosomes which are characterized by enzyme deficiency and thus, are unable to dispose of lipoproteins. The present study was undertaken to investigate the characteristics and changes of lysosomes in the earliest stages of the development of atherosclerosis. Electron microscopic immunocytochemistry revealed that there were certain changes in the distribution of CD68 antigen in lysosomes along the 'normal intima-initial lesion-fatty streak' sequence. There were no significant changes found in the key mRNAs encoding for the components of endosome/lysosome compartment in initial atherosclerotic lesions, but in fatty streaks, the contents of EEA1 and Rab5a mRNAs were found to be diminished while the contents of CD68 and p62 mRNAs were increased, compared with the intact tissue. The study reinforces a view that changes occurring in lysosomes play a role in atherogenesis from the very earlier stages of the disease.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23490339 PMCID: PMC3822815 DOI: 10.1111/jcmm.12042
Source DB: PubMed Journal: J Cell Mol Med ISSN: 1582-1838 Impact factor: 5.310
Characteristics of autopsy material
| Case # | Sex | Age (years) | PMI (hours) | Types of lesion identified | Types of lesion studied |
|---|---|---|---|---|---|
| 1 | M | 31 | 4.5 | I, II | I, II |
| 2 | M | 31 | 4 | I, II, Vc | I, II |
| 3 | M | 39 | 5 | I, II | I, II |
| 4 | M | 40 | 6 | I, II, Vc | I, II |
| 5 | M | 46 | 5.5 | II, Va | II |
| 6 | M | 48 | 5 | II | II |
| 7 | M | 50 | 4 | I, II, Va | II |
| 8 | M | 51 | 4 | I, Va, Vc | I |
| 9 | M | 51 | 6 | II | II |
| 10 | M | 52 | 4.5 | I, II | I, II |
| 11 | M | 53 | 4.5 | I, II, Va | I, II |
| 12 | M | 55 | 4 | I, II, Va, Vc | I, II |
| 13 | F | 39 | 4 | I, II, Va | I, II |
| 14 | F | 44 | 5.5 | I, II | I, II |
| 15 | F | 54 | 4 | I, II | I, II |
| 16 | F | 57 | 4.5 | I, II | I, II |
M: Male; F: Female; PMI: Post-mortem intervals.
All aortas contained areas with the normal (undiseased) intima (not shown in the table).
AHA classification 2, 3.
Type V lesions are defined as lesions in which prominent new fibrous connective tissue has formed 2, 3. When the new tissue is part of a lesion with a lipid core (type IV), this type of morphology may be referred to as fibroatheroma or type Va lesion. A type V lesion in which the lipid core and other parts of the lesion are calcified may be referred to as type Vb. A type V lesion in which a lipid core is absent and lipid in general is minimal may be referred to as type Vc. 2, 3.
Primers used for measurements of mRNAs relevant to the endosomal/lysosomal compartment
| mRNA | Sequence | Size of PCR product, bp |
|---|---|---|
| EEA1 | For 5′-GGAGGAGAGTCTAATCTTGCTTTG-3′ | 182 |
| Rev 5′-GAATCAGTCACCAACCCATCAG-3′ | ||
| Rab5a | For 5′-CAGTTCAAACTAGTACTTCTGG-3′ | 200 |
| Rev 5′-GCTAGGCTATGGTATCGTTCTTG-3′ | ||
| Lamp1 | For 5′-AACTTCTCTGCTGCCTTCTC-3′ | 172 |
| Rev 5′-GAGTGAGTGTATGTCCTCTTCC-3′ | ||
| Lamp2 | For 5′-GATACTTGTCTGCTGGCTACC-3′ | 222 |
| Rev 5′-CATGCTGATGTTCACTTCCTTC-3 | ||
| p62 lck | For 5′-CCGAGTGTGAATTTCCTGAAG-3′ | 144 |
| Rev 5′-CTCTGTGCTGGAACTCTCTG-3′ | ||
| CD63 | For 5′-GTGTGAAGTTCTTGCTCTACG-3′ | 154 |
| Rev 5′-ACTGCGATGATGACCACTG-3′ | ||
| CD68 | For 5′-ATTCATGCAGGACCTCCAGC-3′ | 263 |
| Rev 5′-AGGAGAAACTTTGCCCAAAG-3′ | ||
| GAPDH | For 5′-GAGCCCGCAGCCTCCCGCT-3′ | 145 |
| Rev 5′-GCGCCCAATACGACCAAATC-3′ | ||
| GNB2L1 | For 5′-GAGTGTGGCCTTCTCCTCTG-3′ | 224 |
| Rev 5′-GCTTGCAGTTAGCCAGGTTC-3′ |
Fig. 1Structural appearance of lysosomes in the normal intima (A) and in the initial atherosclerotic lesions (Type I lesion) (B and C) in the human aorta. In (A), note that lysosomes are round- and oval-shaped structures characterized by the presence of homogenous material of middle or high electron density. In (B and C), inclusions within lysosomes are shown by arrows. (A–C): Electron microscopy. Scale bars = 500 nm (A), 200 nm (B and C).
Fig. 2Structural appearance of lysosomes in intimal cells containing ‘lipid droplets’ in intimal cells in fatty streaks (Type II lesions; A–C). Note that, while few lysosomes are characterized by the presence of homogenous material of middle or high electron density, the majority of lysosomes are represented by secondary lysosomes and autophagosomes, containing lipid inclusions. (A–C): Electron microscopy. Scale bars = 200 nm (A–C).
Fig. 3Electron microscopic immunocytochemical demonstration of the distribution of CD68 antigen in lysosomes in cells located in the normal intima (A), the initial lesions (Type I lesions; B and C) and a fatty streak (D) of the human aorta. (A–D): Electron microscopy; Immunogold technique. Scale bars = 200 nm (A–C).
Fig. 4A high resolution micrograph showing the distribution of CD68 antigen in an autophagosome in an intimal cell in a fatty streak of the human aorta. Electron microscopic immunocytochemistry; Immunogold technique. Scale bar = 200 nm.
Fig. 5The ratios of the contents of mRNAs encoding for the components of endosome/lysosome compartment in pairs of atherosclerotically injured/intact human aorta. Black bars: initial lesion/intact tissue ratios; hatched bars: fatty streak/intact tissue ratios. Symbol # shows significant difference from 1.0.
Correlations between the contents of mRNAs encoding for components of endosome/lysosome compartment in normal (undiseased) and atherosclerotically injured areas of the human aorta. Positive correlations are shown as black boxes. Single and double symbols • mark correlations common for two and three tissue types respectively
| mRNA species | Intact tissue | Initial lesion | Fatty streak | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rab5a | Lamp1 | Lamp2 | p62 | CD63 | CD68 | Rab5a | Lamp1 | Lamp2 | p62 | CD63 | CD68 | Rab5a | Lamp1 | Lamp2 | p62 | CD63 | CD68 | |
| EEA1 | •• | • | •• | •• | • | |||||||||||||
| Rab5a | • | • | • | • | ||||||||||||||
| Lamp1 | • | • | ||||||||||||||||
| Lamp2 | •• | •• | •• | |||||||||||||||
| p62 | ||||||||||||||||||
| CD63 | ||||||||||||||||||